Oskar Strom
Overview
Explore the profile of Oskar Strom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
551
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shang Y, Grip E, Modica A, Skroder H, Strom O, Ntanios F, et al.
Diabetes Care
. 2024 Mar;
47(6):978-985.
PMID: 38498331
Objective: Type 2 diabetes (T2D) increases the risk for major adverse liver outcomes (MALOs), including cirrhosis and its complications. Patients with T2D frequently have other traits of the metabolic syndrome...
2.
Franchi M, Gunnarsson J, Gonzales-Parra E, Ferreira A, Strom O, Corrao G
J Clin Endocrinol Metab
. 2023 May;
108(11):e1424-e1432.
PMID: 37235771
Context: Secondary hyperparathyroidism (SHPT) is a complication of chronic kidney disease (CKD) affecting mineral and bone metabolism and characterized by excessive parathyroid hormone (PTH) production and parathyroid hyperplasia. Objective: The...
3.
Geale K, Darabi H, Lindh M, Fues Wahl H, Strom O, Cao H, et al.
Eur Respir J
. 2020 Mar;
55(4).
PMID: 32165398
No abstract available.
4.
Soreskog E, Strom O, Spangeus A, Akesson K, Borgstrom F, Banefelt J, et al.
Bone
. 2020 Feb;
134:115286.
PMID: 32070789
Background: Osteoporosis affects approximately one in five European women and leads to fragility fractures, which result in poor health, social and economic consequences. Fragility fractures are a strong risk factor...
5.
Lauppe R, Akesson K, Ljunggren O, Spangeus A, Ortsater G, Feudjo-Tepie M, et al.
Arch Osteoporos
. 2019 Apr;
14(1):45.
PMID: 30963310
Purpose: This study assesses whether the impact of classical risk factors for fracture due to osteoporosis is different in women aged 80+ and women aged 60-79. Since most prior research...
6.
Svedbom A, Borgstrom F, Hernlund E, Strom O, Alekna V, Bianchi M, et al.
Qual Life Res
. 2017 Dec;
27(3):707-716.
PMID: 29235059
Introduction: The International Costs and Utilities Related to Osteoporotic fractures Study is a multinational observational study set up to describe the costs and quality of life (QoL) consequences of fragility...
7.
Karlsson L, Mesterton J, Tepie M, Intorcia M, Overbeek J, Strom O
Arch Osteoporos
. 2017 Sep;
12(1):81.
PMID: 28936581
Purpose: We evaluated methods of comparing the real-world effectiveness of osteoporosis treatments that attempt to adjust for both observed and unobserved confounding. Methods: Swedish and Dutch registry data for women...
8.
Jonsson E, Eriksson D, Akesson K, Ljunggren O, Salomonsson S, Borgstrom F, et al.
Arch Osteoporos
. 2015 Aug;
10:222.
PMID: 26259867
The objective of this study was to review and describe the current state of Swedish osteoporosis care and to highlight ongoing challenges. This report encompasses quantitative health outcomes based on...
9.
Landfeldt E, Strom O
Bone
. 2012 Jul;
51(4):637-42.
PMID: 22842329
Objective: The objective of this study was to analyze the comparative gastrointestinal tolerability of proprietary versus generic alendronate in patients treated for primary osteoporosis. Methods: The study was based on...
10.
Landfeldt E, Jablonowska B, Norlander E, Persdotter-Eberg K, Thurin-Kjellberg A, Wramsby M, et al.
Hum Reprod
. 2012 Jan;
27(3):760-9.
PMID: 22240210
Background: Little is known concerning patient preferences for IVF treatments. The objective of this study was to elicit patient preferences for characteristics differentiating ovarian stimulation treatments. Methods: Women undergoing IVF...